WO2012169827A3 - 속눈썹 성장용 조성물 - Google Patents

속눈썹 성장용 조성물 Download PDF

Info

Publication number
WO2012169827A3
WO2012169827A3 PCT/KR2012/004540 KR2012004540W WO2012169827A3 WO 2012169827 A3 WO2012169827 A3 WO 2012169827A3 KR 2012004540 W KR2012004540 W KR 2012004540W WO 2012169827 A3 WO2012169827 A3 WO 2012169827A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
eyelash growth
growth
nipradilol
prostaglandin
Prior art date
Application number
PCT/KR2012/004540
Other languages
English (en)
French (fr)
Other versions
WO2012169827A2 (ko
Inventor
강상환
류근호
신동철
이봉용
Original Assignee
에스케이케미칼 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에스케이케미칼 주식회사 filed Critical 에스케이케미칼 주식회사
Priority to JP2014514807A priority Critical patent/JP2014516083A/ja
Priority to US14/124,821 priority patent/US9168212B2/en
Priority to EP12797111.7A priority patent/EP2719383A4/en
Priority to CN201280028218.7A priority patent/CN103732224B/zh
Publication of WO2012169827A2 publication Critical patent/WO2012169827A2/ko
Publication of WO2012169827A3 publication Critical patent/WO2012169827A3/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5578—Eicosanoids, e.g. leukotrienes or prostaglandins having a pentalene ring system, e.g. carbacyclin, iloprost
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

본 발명은 속눈썹 성장에 도움이 되는 약학 또는 화장학적 조성물, 및 속눈썹 성장의 촉진 방법에 관한 것으로서, 유효 성분으로 니프라디롤 또는 이의 약학적으로 허용 가능한 염을 이용하는 것을 특징으로 한다. 본 발명의 조성물은 또한 제 2의 유효 성분으로 프로스타글란딘 F2α 아날로그 화합물을 포함할 수 있다.
PCT/KR2012/004540 2011-06-08 2012-06-08 속눈썹 성장용 조성물 WO2012169827A2 (ko)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2014514807A JP2014516083A (ja) 2011-06-08 2012-06-08 まつ毛成長用組成物
US14/124,821 US9168212B2 (en) 2011-06-08 2012-06-08 Composition for eyelash growth
EP12797111.7A EP2719383A4 (en) 2011-06-08 2012-06-08 COMPOSITION FOR PROMOTING THE PUSH OF THE EYELIES
CN201280028218.7A CN103732224B (zh) 2011-06-08 2012-06-08 用于眼睫毛生长的组合物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2011-0055233 2011-06-08
KR20110055233 2011-06-08

Publications (2)

Publication Number Publication Date
WO2012169827A2 WO2012169827A2 (ko) 2012-12-13
WO2012169827A3 true WO2012169827A3 (ko) 2013-03-07

Family

ID=47296621

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/004540 WO2012169827A2 (ko) 2011-06-08 2012-06-08 속눈썹 성장용 조성물

Country Status (6)

Country Link
US (1) US9168212B2 (ko)
EP (1) EP2719383A4 (ko)
JP (1) JP2014516083A (ko)
KR (1) KR101623132B1 (ko)
CN (1) CN103732224B (ko)
WO (1) WO2012169827A2 (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD841152S1 (en) 2017-06-27 2019-02-19 Monica S. Naylor Eye drop container
KR102451841B1 (ko) * 2018-10-25 2022-10-07 (주)아모레퍼시픽 속눈썹 성장 촉진 효능을 갖는 물질의 스크리닝 방법

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262105B1 (en) * 1997-02-04 2001-07-17 Murray A. Johnstone Method of enhancing hair growth
KR20060120424A (ko) * 2005-05-19 2006-11-27 코와 가부시키가이샤 녹내장 예방 또는 치료제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04224522A (ja) * 1990-04-27 1992-08-13 Merck & Co Inc 繊維芽細胞増殖因子含有組成物による禿頭症の治療又は予防方法
JP4261912B2 (ja) * 2001-04-19 2009-05-13 テイカ製薬株式会社 薬剤および薬剤キット
US8628756B2 (en) * 2005-12-30 2014-01-14 Revance Therapeutics, Inc. Arginine heteromers for topical administration
SG193840A1 (en) * 2008-09-04 2013-10-30 Santen Pharmaceutical Co Ltd HAIR GROWTH PROMOTING AGENT CONTAINING 15,15-DIFLUOROPROSTAGLANDIN F2a DERIVATIVE AS ACTIVE INGREDIENT

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262105B1 (en) * 1997-02-04 2001-07-17 Murray A. Johnstone Method of enhancing hair growth
KR20060120424A (ko) * 2005-05-19 2006-11-27 코와 가부시키가이샤 녹내장 예방 또는 치료제

Also Published As

Publication number Publication date
CN103732224B (zh) 2016-06-01
JP2014516083A (ja) 2014-07-07
KR20120136306A (ko) 2012-12-18
US9168212B2 (en) 2015-10-27
WO2012169827A2 (ko) 2012-12-13
US20140194501A1 (en) 2014-07-10
KR101623132B1 (ko) 2016-05-20
EP2719383A4 (en) 2014-12-17
CN103732224A (zh) 2014-04-16
EP2719383A2 (en) 2014-04-16

Similar Documents

Publication Publication Date Title
WO2013142817A3 (en) Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo
WO2012021715A3 (en) Stable formulations of linaclotide
WO2013091775A3 (de) Verwendung von cyclohexanolderivaten als antimikrobielle wirkstoffe
WO2010114405A3 (en) Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same
WO2010092090A3 (en) Novel salts of sitagliptin
WO2013100566A8 (en) Phenyl alkyl carbamate derivative compound and pharmaceutical composition containing the same
WO2012161497A3 (ko) 보습능이 우수한 펩타이드 유도체 및 이의 용도
EA201201109A1 (ru) Прасугрель в тонкоизмельченной кристаллической форме и фармацевтическая композиция, содержащая его
ZA201500362B (en) Novel compound having ability to inhibit 11b-hsd1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient
MX2016001422A (es) Composicion farmaceutica de fingolimod.
EP2796450A4 (en) 6-AMINOPYRIDINE-3-OL DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, AND PHARMACEUTICAL COMPOSITION CONTAINING THESE DERIVATIVES OR THESE SALTS AS ACTIVE INGREDIENTS FOR THE PREVENTION OR TREATMENT OF ANGIOGENESIS DISEASES
EP2722042A4 (en) INDANONE DERIVATIVES, THEIR OPTICAL ISOMERS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING VIRAL DISEASES
MD4563C1 (ro) Produs de comicronizare cu conţinut de acetat de ulipristal
WO2015001163A3 (es) Nanopartículas lipídicas para la cicatrización de heridas
WO2011145872A3 (ko) 탈모방지 또는 육모 촉진용 조성물
WO2012002773A3 (en) Phenylcarbamate compound and muscle relaxant containing the same
WO2014178789A9 (en) Topical composition and carrier for administration of pharmaceutically or cosmetically active ingredients
MX357704B (es) Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide.
WO2012116254A3 (en) Chrysophaentin analogs that inhibit ftsz protein
WO2012169827A3 (ko) 속눈썹 성장용 조성물
EP2722322B8 (en) 1,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient
EP2742950A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING FIBULIN-3 PROTEIN AS AN ACTIVE INGREDIENT FOR INHIBITING GROWTH OF CANCER STEM CELLS
WO2011161245A3 (en) Polymorphs of febuxostat
EP3995570A4 (en) COMPOSITION FOR PROMOTING THE PROLIFERATION OF STEM CELLS, CONTAINING, AS AN ACTIVE PRINCIPLE, CP1P OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
WO2012047007A3 (ko) 손톱 또는 발톱 성장 촉진용 조성물

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12797111

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2014514807

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2012797111

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 14124821

Country of ref document: US